Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma.
about
Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionThe tumor microenvironment in esophageal cancerSystematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinomaMet receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodiaMET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit.Receptor-tyrosine-kinase-targeted therapies for head and neck cancer.HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancerAssociation of angiogenic factors with prognosis in esophageal cancer.MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell linesc-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic targetmiR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.Genomic alterations in advanced esophageal cancer may lead to subtype-specific therapies.Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis.Lentivirus-mediated RNA silencing of c-Met markedly suppresses peritoneal dissemination of gastric cancer in vitro and in vivo.Molecular imaging for guiding oncologic prognosis and therapy in esophageal adenocarcinoma.Emerging tyrosine kinase inhibitors for esophageal cancer.Role of met axis in head and neck cancer.Emerging mAbs for the treatment of esophagogastric cancer.EGFR family and cMet expression profiles and prognostic significance in esophagogastric adenocarcinoma.Integration of targeted agents in the neo-adjuvant treatment of gastro-esophageal cancers.Targeting key signalling pathways in oesophageal adenocarcinoma: a reality for personalised medicine?Prognostic role of c-met expression in breast cancer patients.Clinical and prognostic value of the C-Met/HGF signaling pathway in cervical cancer.Impact of serum biomarkers on esophageal squamous cell carcinoma
P2860
Q27026253-BE13A097-BC00-4A94-BD72-B55A92C4CD81Q28077074-6F07E40E-50DC-49FD-8B97-81E18D86EE4FQ28085367-277D0CBB-5B7A-47B2-9C5F-8EB27A82BE63Q30010161-A45D9204-7676-44B7-A8C3-D373FDD836DEQ33688421-92F79B43-2B68-49A3-A5DB-CA08B2DB9E3DQ35102025-3010C5B1-9F39-4B73-9661-85DC976D7910Q35174872-5C36112E-97A1-453E-84A1-515DDA34C7ADQ35185524-D53C57A9-7FAB-4A6F-9F41-EAACF41B5412Q35208173-2BA85028-BD77-4A8F-94DB-DAAF4E2D4B2DQ35650167-24E871CE-278C-4C7D-8666-C2FCDFA80A34Q36983766-39D30437-EC86-45D5-B300-3207A97AF120Q37038482-530DC14D-7A80-4158-A4EE-6A98B49264BCQ37246675-19ECECBA-C365-4E3D-9672-0658B8C198DAQ37522222-A2E5B57C-1BDA-439F-9941-46C85B3F4AF3Q37729958-EB2187EE-8215-4F5B-A560-4B470F7A81C0Q37876081-BBCE51D7-886E-47DA-8913-3D65B886697AQ38110962-AB37BB73-4CCD-4178-B7FE-8C0BC3056787Q38167258-70577839-0A25-403A-BB69-69F3D7BE6805Q38284597-6550E912-EB2F-42A6-8386-687C9690AE63Q39025928-01772B89-3D69-4F78-B81C-F8DB2A7B15B7Q39933959-E386C248-BF6B-4485-A97F-C891A1B6128EQ42769520-7F3867F9-B2DA-4D95-B71B-C0E9C8A9F568Q42794653-9E686454-CF12-4014-A3F1-16FC31EA09BBQ47616848-E00AD685-827E-4C03-9033-60852F791F66Q57707731-489AEC35-2247-4026-8ABB-2C53EF574A42
P2860
Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Met expression is an independe ...... th oesophageal adenocarcinoma.
@ast
Met expression is an independe ...... th oesophageal adenocarcinoma.
@en
type
label
Met expression is an independe ...... th oesophageal adenocarcinoma.
@ast
Met expression is an independe ...... th oesophageal adenocarcinoma.
@en
prefLabel
Met expression is an independe ...... th oesophageal adenocarcinoma.
@ast
Met expression is an independe ...... th oesophageal adenocarcinoma.
@en
P2093
P2860
P356
P1476
Met expression is an independe ...... th oesophageal adenocarcinoma.
@en
P2093
D J Richel
F J W Ten Kate
J B Tuynman
J J B van Lanschot
S M Lagarde
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604251
P407
P577
2008-03-18T00:00:00Z
P5875
P6179
1036865649